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Abstract This paper investigates the benefits of using less
intrusive wireless technologies for heart monitoring. By
replacing well established heart monitoring devices (i.e.
Holter) with wireless ECG based Body Area Networks
(BAN), improved healthcare performance can be achieved,
reflected in (1) high quality ECG recordings during
physical activities and (2) increased patient satisfaction. A
small scale clinical trial was conducted to compare both
technologies and the results illustrate that the wireless ECG
monitor was able to detect ECG signals intended for
arrhythmia diagnostics. Furthermore, from a patient’s
perspective, both technologies were evaluated using three
dimensions, namely; hygienic aspects, physical activity,
and skin reactions. Results demonstrate that the wireless
ECG BAN showed better performance, especially regarding
the hygienic aspects. It was also favourable for use during
physical activities, and the signal quality of the wireless
sensor system demonstrated good performance regarding
signal noise and artefact disturbances. This paper concludes
that wireless cardiac monitoring systems have significant
benefits from a patient’s perspective, and further clinical
trials should be conducted to further evaluate the new ECG
based BAN system, to identify the possibility of wide-
spread adoption and utilisation of wireless technology for
arrhythmia diagnostics.
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Arrhythmia diagnostics . Patient satisfaction .
Remote patient monitoring
Introduction
Disease management programmes involving ECG home
monitoring are expected to play a key role in the safety and
cost effectiveness of future health-care services [1]. New
wireless technologies open up possibilities for the monitor-
ing of vital sign parameters using wearable biomedical
sensors. The aim of using these technologies is to improve
the quality of care/service, reduce the cost of caring for
patients and facilitate home healthcare. This paper evaluates
the performance of a new wireless ECG BAN technology
against an existing wired technology, the Holter monitor (c.f.
Fig. 1a). In the future we assume the wireless device can be
utilised for early arrhythmia diagnostics e.g. arrhythmia
control when adjusting a patient’s medication. Our paper
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examines performance issues from the perspective of the
signal quality of the ECG recordings from the ECG BAN, as
well as patient satisfaction with wearing this device. It
illustrates that wireless technologies in the area of cardiac
monitoring have the potential to significantly improve patient
care management. It concludes by discussing the issues
which need to be addressed to enable wireless BAN
technologies to be adopted for cardiac monitoring.
The remainder of this paper is structured as follows. The
literature in the area is reviewed and concludes that if
wireless technologies are to be adopted by medical practi-
tioners, such devices must be proven to be as reliable as the
widely used Holter monitor. Furthermore, it reveals a lack
of research focusing on a patient’s perception of these
devices. It outlines the objective of this study which is “to
determine the way in which wireless ECG BAN recording
technologies can be used by medical practitioners as an
arrhythmia diagnostic tool, and to evaluate the patient
satisfaction of using wireless ECG based BANs”.
The paper proceeds by documenting the three stage
research approach adopted for this study and presents the
initial findings. The paper concludes by highlighting key
issues associated with remote patient monitoring and
further research directions.
Literature
The application of wireless technologies in a healthcare
context is not new [c.f. [2–9]. In particular, the adoption
and utilisation of these wireless technologies is growing
rapidly as hospitals and medical equipment firms realise the
benefits which can be delivered [10, 11]. As the safety and
reliability of these systems improves, hospitals are now
more willing to adopt wireless solutions [11]. Researchers
[10, 11] also note that devices for the treatment of chronic
health conditions represent an opportunity to empower
patient’s to control their treatment. They argue that patient
care is improved by the less intrusive nature of wireless
technology and when implemented, a wireless solution
should reduce the impact of treatment on the lifestyle of
the patient and improve their health outcomes in the long
term.
With new technologies continuously being investigated
in terms of their applicability to healthcare, it is important
to investigate if healthcare performance improves as a result
of utilising these technologies. In healthcare, performance
has primarily been investigated in terms of how technology
facilitates performance improvements in administrative
tasks [12]. However, research is limited on the adoption
of new technologies by medical practitioners for diagnostic
purposes and the resulting performance implications [11].
Furthermore, the investigation of patient issues in relation
to new technologies is an area devoid of study with the
issues faced by patients not being explored. We argue that
such research would provide insights into why particular
technological innovations are not widely adopted and
utilised by medical practitioners in their day to day
activities.
Technology constraints
In the area of cardiac monitoring, Holter monitors have
long been used for the detection of arrhythmia situations
[13], and those wearable monitors are used at out-patients’
clinics for cardiac monitoring to diagnose arrhythmias
because of their accuracy and reliability in relation to:
1. The quality in the ECG signal,
2. The accuracy of the R-wave detections, and
3. The arrhythmia detection performance.
Their performance in relation to these criteria is key in
explaining why they are the industry standard and used the
world over by medical practitioners for cardiac monitoring.
However, the Holter monitor can be characterised as having
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Fig. 1 Wired holter monitor (a)
vs wireless ECG BAN (b) and
corresponding HHD device
shown on the patient
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a number of performance issues, which are summarised in
Table 1. Its limitations include [14, 15]:
1. Its restricted recording time due to a limited storage
capacity,
2. A large amount of wires connecting the device to the
patient, and
3. A lack of real-time data.
From a general practitioner’s perspective, the biggest
disadvantage of using the Holter technology is that the data
is not real-time which in a medical context makes the
possibility of instant diagnosis impossible. It may be a
number of days before a medical prognosis is made, which
in certain instances may be fatal [15]. Correct diagnosis will
normally be given by a cardiology specialist, and the
possibilities for a general practitioner to use a Holter as a
quick diagnostic procedure is thus limited.
From a patient’s perspective, there are also shortcomings
with the Holter Monitor. Firstly, it is large and heavy [14]
with patients required to wear it for a minimum of 24 hours
and in many cases for a period of up to 1 week, depending
on the specific medical condition of the patient. A patient’s
mobility is severely hampered when wearing a Holter
monitor [14]. For instance, a patient can’t take a shower or
bath while attached to the monitor [13], as this will destroy
the electronics in the recording device. Difficulties can also
arise with sensors becoming unattached due to patient
movement [16, 17], which will give artefact disturbances to
the recorded signals. Furthermore, there is also a large
amount of ‘stigmatisation’ [18] associated with wearing the
device. To summarise, in terms of the Holter monitor, there
are performance issues from both the general practitioner
and patient perspectives.
Such limitations have resulted in researchers exploring
how other technologies can facilitate cardiac monitoring,
for example wristwatch technology [4], mobile phones [19]
and Bluetooth technology [20]. Yet, in all cases, the
performance issues, in relation to the diagnostic perfor-
mance of these devices result in the majority of general
practitioners not willing to adopt these technologies. Yet the
issues (outlined in Table 1) with the incumbent Holter
monitor technology still remain, predominately based on a
wired non real-time connection to the patient [c.f. [21].
Methods
In order to perform continuous ambulatory ECG recordings, a
new wireless ECG based BAN was developed, and Fig. 2
shows a photograph of the ECG BAN prototype which
incorporates analog amplification circuits, a radio transmitter
and a battery. The unit is disposable with an adhesive surface
underneath the ECG patch; thus it is uncomplicated to use
and can easily be applied to a patient’s chest. A very strong
single ECG patch is used as opposed to the traditional multi-
patch Holter monitor (c.f. Fig. 1). The patch is positioned at
the upper left part of the chest. The Holter recorder was used
according to normal procedure at the hospital with five
electrodes in a standard five-lead system [22].
 
Radio,
electronics
& battery
Single
ECG Patch
Fig. 2 ECG BAN prototype
used in the clinical trials. c.f.
Fig. 1b (attached to patient)
Table 1 Performance issues with the Holter monitor
Patient Medical practitioner
Stigmatisation Less reaction time due to lack of real-time data
A lack of timely intervention Manual retrieval of data (time consuming)
Lack of mobility
A large number of visits and a large percentage of time spent at hospital
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The ECG based BAN measures one ECG signal and
continuously transmits the signal to a Wireless Handheld
Device (HHD). The ECG BAN device facilitates secure
communication to the HHD as a common gateway to
transmit the actual recordings to a designated doctor
(illustrated in Fig. 3). The wireless ECG BAN solution
was developed by WPR Medical, Arendal, Norway [23].
While the HHD receives and analyses the ECG signal, if
an abnormal cardiac signal is encountered, the HHD device
will start transmitting the recorded ECG signal to the
cardiology specialist at the hospital. In a hospital or private
alarm centre, the alarm will be raised by the operating
personnel and the system can display the actual recorded
ECG signals received from the patient. However, as it is in
the early stage of development, this automatic transmission
functionality was not incorporated into the prototype used
in our study.
The objective of this research is “to determine the way in
which wireless ECG BAN recording technologies can be
used by medical practitioners as an arrhythmia diagnostic
tool, and to evaluate the patient satisfaction of using
wireless ECG based BANs”. A three stage approach was
adopted to operationalise this study and meet its objective.
Stages one and two took place in the cardiac out-patient
clinic at Sørlandet Hospital, Arendal, Norway. The perfor-
mance of both technologies (the Holter monitor and the
wireless ECG BAN) was compared with the purpose being
to assess the performance in terms of ECG signal quality
and patient satisfaction. This clinical trial was designed
with patients wearing both the conventional Holter monitor
and the wireless ECG BAN technology at the same time for
1 day. Thus, simultaneous recordings made by the two
devices could be compared and correlated. Patients referred
to long term ambulatory (Holter) procedures at the
outpatient cardiology clinic at Sørlandet Hospital, Arendal,
Norway were asked to participate in the clinical trial. After
signing the informed consent form, they participated in the
study during their arrhythmia investigation. The inclusion
criteria was patients with suspected arrhythmia and the
exclusion criteria was patients with dementia who were not
able to handle the equipment. Eleven patients signed up for
the clinical trial which took place between November 2006
and May 2007. In addition, a reference group (those who
were examined using only the Holter monitor) of 25
patients were recruited to study patients’ experiences in
relation to using the Holter monitor during a “normal”
arrhythmia investigation procedure. A Sensor Acceptance
Model [18] was utilised to assess patient satisfaction, and
the patients had to fill in a detailed questionnaire. This
model assesses patient’s satisfaction in relation to anxiety,
skin reaction, equipment, hygienic aspects and ease in
conducting physical activity. Patient’s characteristics are
presented in Table 2.
As a follow on (stage three), the wireless equipment was
made available to a general practitioners office. This
facilitated the testing of a decentralised medical expert
diagnostic service. General practitioners at two health
centres in Arendal, Norway were educated to apply the
wireless ECG BAN to the patient’s chest and use this
technology as a decentralised arrhythmia diagnostic solu-
tion. The rationale for this trial was an attempt to perform
this medical diagnostic procedure in closer proximity to the
patient’s natural surroundings and to reduce the number of
visits to cardiologists which are located in centralised care
units in Norway. The procedure in selecting the patients
was the same as that used in the hospital stage of the
clinical trial, and the patients only had to wear the wireless
ECG system for 3 days. The wireless ECG BAN used in
this study stored the recorded ECG signals in an internal
memory chip. This chip was sent to the cardiology
specialists at Sørlandet Hospital in Arendal Norway, in
Table 2 Patient characteristics (n=36)
Group Number Gender
(male/female)
Age
Mean (SD) Min Max
Wireless 11 6/5 40.2 (19.4) 11 67
Reference
(Holter)
25 7/18 56.4 (13.2) 36 77
Fig. 3 Several wireless sensors can communicate with a wearable
hand held device (HHD) forming a Body Area Network which can act
as a gateway to transmit the actual ECG signal to the doctor by use of
mobile phone data transmissions e.g. GPRS
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order for the cardiology specialists to evaluate the record-
ings in a similar way as the traditional Holter.
It was essential to evaluate whether the wireless ECG BAN
could be used in everyday life situations, and it was assumed
that recorded signals could give higher diagnostic yield
compared to situations where the patient is restricted or
limited in their physical activities. The primary goal of devel-
oping a wireless ECG BAN was to find ways of monitoring
the everyday life of the patient as closely as possible.
During following up interviews carried out in the
patient’s home, patients were asked about their experience
with ECG BAN and how they managed this technology.
We tried to identify important factors for the patient’s
acceptance of the wireless ECG BAN and to evaluate to
what degree the patient accepts it [24]. This was a
phenomenological study based on Giorgi’s theory [25],
therefore, the methods used for the patient’s acceptance
include a combination of quantitative and qualitative data
gathered using the sensor acceptance model and phenom-
enological interviews.
The study has been accepted by the Regional Ethical
Committee as well as the hospital’s Ethical Committee, and
permission with respect to data privacy requirements was
given by the Norwegian Social Science Data Services on
behalf of The Norwegian Data Inspectorate. The permission
to use the developed prototype in a clinical study was given
by the Directorate for Health and Social Affairs in Norway,
as this equipment does not yet have a CE conformance
declaration.
Results
This section outlines the findings of the three stages in this
study.
Stage 1: Evaluation of ECG recordings: Holter vs. wireless
ECG BAN
If wireless technologies are to be adopted by general
practitioners to assess cardiac arrhythmias, such devices
must be proven to be at least as reliable, if not better, than the
existing Holter technology. Printouts were collected from the
wireless ECG BAN and corresponding time sequences of
the Holter recordings. An example of an actual recording is
presented in Fig. 4, where the three upper curves are from
the Holter recorder while the lowest curve is from the
wireless ECG BAN. The QRS complexes from the Holter
and Wireless ECG BAN produce comparable results. Each
system detects the R-wave and prints the R–R interval in
milliseconds (shown as digits on the top). In addition, the
annotations for each R-wave describes whether this was
detected as a normal beat (N), a supraventricular extra
systoles (S) or a ventricular extra systoles (V).
Fig. 4 Printouts from a three-lead Holter (at the top) and the one-lead wireless ECG BAN (underneath)
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A comparison of R–R intervals
As it is essential in correct detection of arrhythmia situations
that the monitoring device shows a precise interpretation of
the R-wave within the QRS complex in the ECG recordings, a
correlation analysis method was used to compare the actual
recordings. On the recorded ECG curve printouts, the actual
interval between two R-waves, are given at the top of the
curves in milliseconds.
By comparing a time sequence for exactly the same
heartbeats recorded by two different devices, it is possible
to calculate Pearson’s r correlation coefficient. A correla-
tion plot for a single patient is presented in Fig. 5, showing
a strong correlation (r=0.998, n=131, p<0.0005). Similar
correlations were calculated from another five patients
where it was possible to identify exactly the corresponding
time series of heart beats from the two devices, showing
good correlations with r>0.998 for all the sequences. The
correlation analysis method of Bland and Altman [26] have
also been performed by calculating the difference of the
mean and the bias defined by the mean difference and the
standard deviation of the difference. It was found that a
deviation between the two systems within the range of −6
to +7 ms, which corresponds to ±1% of the mean R–R
interval, can be considered as near identical for any prac-
tical purpose.
In order to assess the quality of the results originating
from the wireless ECG BAN against the Holter monitor,
two independent and experienced cardiologists reviewed
the results from both approaches. The recording quality of
an ECG may vary (as a result of patients’ movement and
physical activity), and a total of 103 recorded ECG
sequences of 30 seconds duration were evaluated. The
cardiologists gave their scores evaluating the quality of the
recording curve regarding its usefulness in arrhythmia
diagnosis in terms of whether they would be able to give
a valid interpretation of the recorded ECG sequence, using
a five-point Likert scale (5—very good, 4—good, 3—
acceptable. 2—poor, 1—not acceptable). Comparisons of
scores from the two systems are given in Table 3.
The cardiologists’ evaluations showed that the differences
between the two recording devices were small and not
statistically significant (p=0.2). Analysis revealed that the
Holter monitor was more exact for precise arrhythmia
annotations, while the wireless system in some instances
did not give correct annotation for the extra systoles (S or V).
During patients’ physical activities, the signal quality of
the wireless ECG BAN demonstrated good performance
and adequate ECG recordings in relation to signal noise and
artefact disturbances.
In some of the wireless recordings the P-wave amplitude
was relatively low; however, in all sequences it was
possible for a cardiologist to make a correct interpretation
of the arrhythmias detected. The cardiologists believed the
reason for the low P-wave amplitude was the actual
position of the patch on the chest, and if the patch was
placed at the upper left part of the chest (above the left
breast), the quality of the P-waves would be improved.
It is therefore reasonable to conclude that the differences
between the two recordings, with regard to their ability to
perform arrhythmia diagnostics, were minor and that the
evaluations of the ECG signals obtained with the wireless
ECG BAN device showed promising levels of recording
quality for the purposes of arrhythmia diagnosis.
Stage 2: Patient satisfaction: Holter vs. wireless
As in the medical practitioner’s case, the performance of
the new wireless ECG BAN device is compared to the
existing Holter monitor in order to determine the patients’
satisfaction with both technologies. Patients’ perspectives
Fig. 5 Correlation plot with the actual R–R intervals given in
milliseconds, and with results from the Holter recorder on the X-axis
and from the wireless ECG BAN on the Y-axis. Number of R–R
intervals in the continuous sequence was 131, and showed a strong
correlation (r=0.998, p<0.005)
Table 3 Independent cardiologists’ evaluation of the usefulness in arrhythmia diagnostics for the two systems; the Holter recorder and the
wireless ECG BAN, where a total number of 103 ECG sequences were evaluated
Evaluator factor Total score Holter Wireless
N Mean SD N Mean SD N Mean SD
Usefulness in arrhythmia 103 3.45 0.98 44 3.60 1.00 59 3.34 0.96
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on both technologies were evaluated using the following
dimensions: hygienic aspects, physical activity, and skin
reactions. Scores were given using an 11-point semantic
differential scale, where the patients evaluated their
experience of using the wireless device and the Holter
monitor. The performance of the Holter and wireless ECG
BAN across the various patient satisfaction dimensions is
summarised in Table 4.
The Holter monitor performed better in terms of skin
reaction (p<0.05). This can be explained by a larger
medical patch for the wireless sensor compared to the
normal multi-patch ECG electrodes employed by the
Holter. In terms of hygienic aspects, there was a significant
difference between the 2 systems, with a significantly
higher score for the wireless ECG BAN (p<0.05).
The hygienic aspects focused on tasks related to the
patient’s ability to have a bath/shower and to use the
equipment during the night while sleeping. The survey
showed a significant difference between the two devices (p<
0.05), with the wireless ECG BAN being preferable. With
the wireless ECG BAN, the patients had the possibility to
have a shower, in contrast to the Holter system. Furthermore,
the wireless ECG BAN was less heavy and cable free.
In seeking to understand patients’ satisfaction with both
technologies, a series of interviews were conducted. One
patient complained about the Holter recorder and stated that
he had a feeling of “being a living medical instrument”
because of all the cables he had to wear. With regard to the
wireless ECG BAN, he stated “the wireless sensor was
comfortable to wear and most of the time I forgot I was
wearing it”. He said that after a while the ECG BAN
became “a part of me”. In terms of mobility, a number of
patients expressed the advantage of performing physical
exercise while monitored.
The patients reported they were able to participate in
football games, outdoor jogging, aerobics and similar
activities. This represents a clear advantage of the wireless
ECG BAN giving the patients a much greater possibility of
carrying out the activities of daily living (ADL) without any
obstacles.
Stage 3: Decentralisation to the general practitioner’s office
To evaluate the wireless ECG BAN as part of a decentral-
ised initiative for cardiac monitoring (proximity of patient
to GP), it was made available at a GP’s office. For this stage
of the study, a trained nurse applied the ECG BAN to the
patient’s chest, and instructed the patient on how to use the
device and perform overnight charging of the HHD. After a
predetermined time, normally 3 days, the patient had to
return the equipment to the GP’s office. The internal
memory storage chip in the HHD was then manually
transferred to the cardiologist at the hospital, to facilitate
arrhythmia analysis. The GP subsequently received a report
from the cardiologist which facilitated diagnosis and
treatment of the patients by the GP without the need for
them to travel a large distance in order to attend the
cardiologist’s clinic. Five patients participated in this aspect
of the study in the period from May to June 2008. In
evaluating this part of the clinical trial, the researchers
focused on the patients experiences with the wireless ECG
BAN. During phenomenological interviews the researchers
documented patients’ experience in using this device.
Analysis from these interviews provided key insights on
patient’s performance, in relation to physical, psychological
and social dimensions (c.f. Table 5).
As presented in Table 5, the wireless ECG BAN made it
possible to participate in physical exercise; this was
positively evaluated by the patients. Patients reported that
management of the sensor was easy and unproblematic;
Table 5 Patient performance indicators for decentralised solution (home healthcare)
Performance indicator Patient insights
Physical dimension Ability to conduct normal daily activities e.g. shopping, walking etc without thinking about wearing the sensor.
Patients reported that intensive physical activities were also possible.
Psychological dimension Reduction of anxiety both for the patient and spouse/partner.
Feeling of safety increased.
Social dimension Ability to function in normal social situations.
They went to town, went shopping and participated in meetings.
Table 4 Results from the questionnaires, mean (SD) for the three
dimensions calculated
Dimensions Wireless sensor
(n=11)
Reference group
(n=25)
Hygienic aspects 8.6 (1.6) 6.6 (2.9)*
Physical activity 9.2 (0.8) 8.0 (2.8)
Skin reactions 6.3 (2.5) 8.6 (2.4)*
A high score for the dimension Anxiety indicate the patient shows a
low degree of anxiety.
*p<0.05 significant difference
J Med Syst (2010) 34:767–775 773
however, they wanted a visual display to indicate the sensor
system was working properly. With the wireless ECG BAN
available at their local GPs office, patients felt that quality
of care given by the GP was improved. Therefore in
summarising the wireless technology from a patient’s
perspective (both at the hospital and home trials), four
issues were noted:
1. Stigmatisation
& Some patients wish to hide a cardiac monitor from
the general public. Our analysis revealed that this
was a problem with the Holter monitor, however
stigmatisation was not an issue with the wireless
ECG BAN. The equipment is not a hindrance to the
patients’ activities of daily living (ADL), including
physical sport activities. It enables the recording of
cardiac arrhythmias under more strenuous physical
conditions, which are very difficult to capture with
the Holter monitor due to noise and artefact
disturbances during activity.
2. Need for feedback from the system
& Some of the patients were concerned about not
receiving any feedback from the recording system;
whether it was operating as normal or not. A
display on the hand-held device indicating proper
system functions is recommended so the patient can
be sure that the wireless ECG BAN is functioning
correctly.
3. Need for feedback from health personnel
& Some patients reported that they wanted quick
reaction and feedback from their medical practi-
tioner regarding their arrhythmia diagnosis. Quick
feedback from the hospital/doctor to the patients
regarding findings will be dependant on the
routines at the hospital and the GP’s office.
4. Patients expressed confidence when using the wireless
ECG BAN
& The wireless technology is easy to use.
& The patients felt no discomfort wearing the wireless
ECG BAN.
& Reduced waiting time for treatment through a
decentralised cardiac monitoring model.
Discussion
This investigation showed that there are advantages
associated with wireless cardiac monitoring. The wireless
ECG BAN illustrated significant benefits for the patients,
especially regarding the hygienic aspects; probably because
the patient’s ability to have a shower and to use the
equipment during the night while sleeping with little or no
discomfort; “no cable spaghetti”.
However, in this small scale study only a limited number
of patients have been included, thus limiting the general-
isability of the results. The patient’s age in the reference
group was significantly higher than in the wireless group
(p<0.05). In the reference group, the majority of patients
were older females; this can represent a bias especially in
the evaluation of user acceptance as many of them would
not have a physically active lifestyle necessitating an easy
to wear sensor system.
As part of this study, a total of 103 ECG sequences were
compared by two independent cardiologists, and this
sample is too small to give calculations of validity and
reliability, and thus we can only give some tentative
indications of the wireless ECG BAN’s performance. The
number of arrhythmic episodes was also limited, and the
ability of the wireless ECG BAN to detect significant
arrhythmias must be tested in larger studies. Specifically, it
will be important to detect significant P-wave amplitudes as
the timing from the P-wave to the R-wave is important for
arrhythmia diagnostics. In this study, we have discovered
differences in the P-wave amplitude recorded, indicating
the actual position of the patch on the patient’s chest is a
critical factor. We also discovered that the signal quality
from the wireless ECG BAN during the patients’ physical
activity showed acceptable quality regarding low signal
noise and limited artefact disturbances.
Conclusion and further research
This paper discussed the performance issues associated
with two devices which can be utilised for cardiac
monitoring. It illustrates that by utilising wireless technol-
ogy, healthcare performance, especially from a patient’s
perspective, can be improved and that the quality of results
recorded with the wireless ECG BAN is high. Therefore, it
can be concluded that wireless cardiac monitoring systems
may provide significant opportunities for improved health-
care from a patient’s perspective. However, this pilot study
was the first initial step in evaluating the wireless ECG
BAN technology and further clinical studies are required.
For the evaluation of patient acceptance, a triangulation
of methods was used. In this clinical trial the number of
patients was limited, but some interesting aspects have been
discovered in relation to integration into the patients’
everyday life. Further investigation in this area is required.
Specifically, a patient’s ability to participate in physical
activities while still being monitored for arrhythmia
occurrences are of special importance.
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In extending this research, the authors are focusing on
four distinct, yet interrelated areas:
& Further developing hardware and software necessary to
support the wireless ECG BAN architecture.
& Conducting a large scale clinical trial evaluating the
results from the wireless ECG BAN.
& Exploring possibilities of business re-engineering of
healthcare services and information flows between the
cardiologist and the GP.
& Investigating the implications for general practitioners
and healthcare providers of adopting this wireless ECG
BAN, specifically focusing on a quality, efficiency and
cost (QEC) analysis.
Overall, such research will provide us with further
insights in relation to the potential for wireless ECG based
BANs to complement and in the future replace the
traditional Holter monitors for cardiac arrhythmias.
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